For the quarter ending 2026-03-31, QSIAW had $14,561K increase in cash & cash equivalents over the period. -$25,917K in free cash flow.
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|
| Net loss | -21,671 | -17,611 | -83,728 |
| Depreciation and amortization | 1,225 | 1,173 | 3,281 |
| Allowance for credit losses | - | 146 | - |
| Non-cash lease expense | 366 | 375 | 1,934 |
| Loss on lease termination | - | 0 | 2,260 |
| Write-off of construction on process due to lease termination | - | 0 | 1,162 |
| Unrealized gain on trading securities, net | - | 0 | - |
| Realized loss on trading securities | - | 0 | - |
| Accretion on marketable securities | 888 | 1,564 | 6,458 |
| Loss on disposal of fixed assets | 0 | 0 | -31 |
| Write-down of inventory | 1,284 | 533 | 1,757 |
| Change in fair value of warrant liabilities | -357 | -279 | -3,923 |
| Change in fair value of contingent consideration | - | 0 | - |
| Stock-based compensation | 2,565 | 2,688 | 8,085 |
| Other | - | 1 | 0 |
| Accounts receivable, net | -358 | -48 | -578 |
| Legal settlement insurance receivable | -4,638 | 0 | 4,638 |
| Inventory | 278 | 1,017 | 989 |
| Prepaid expenses and other current assets | 678 | 1,316 | 247 |
| Operating lease right-of-use assets | - | 0 | - |
| Other assets | - | -1 | -2 |
| Accounts payable | 316 | 145 | -483 |
| Accrued expenses and other current liabilities | -4,053 | 788 | -2,283 |
| Accrued legal settlement liability | -8,000 | 0 | 8,000 |
| Operating lease liabilities | -455 | -444 | -2,737 |
| Other long-term liabilities | -10 | -12 | 26 |
| Net cash used in operating activities | -25,638 | -16,347 | -78,370 |
| Purchases of property and equipment | 279 | -17 | 2,534 |
| Internally developed software - capitalized costs | - | 0 | 0 |
| Purchases of marketable securities | 64,150 | 109,371 | 295,210 |
| Sales and maturities of marketable securities | 104,700 | 116,378 | 262,400 |
| Net cash provided by (used in) investing activities | 40,271 | 7,024 | -35,344 |
| Proceeds from exercise of stock options | 0 | 50 | 1,862 |
| Proceeds from vesting of restricted stock | - | 1 | - |
| Proceeds from issuance of common stock from direct equity offerings, net of fees and issuance costs | 0 | 3 | 93,507 |
| Proceeds from issuance of common stock from at-the-market offering, net of commissions and issuance costs | - | 0 | - |
| Deferred offering costs | - | 0 | 0 |
| Refund of issuance costs | - | 0 | 0 |
| Net cash provided by financing activities | 0 | 54 | 95,369 |
| Effect of exchange rate changes on cash and cash equivalents | -72 | -2 | 14 |
| Net increase (decrease) in cash and cash equivalents | 14,561 | -9,271 | -18,331 |
| Cash and cash equivalents at beginning of period | 21,639 | 30,910 | 49,241 |
| Cash and cash equivalents at end of period | 36,200 | 21,639 | 30,910 |
Quantum-Si Inc (QSIAW)
Quantum-Si Inc (QSIAW)